Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis

Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.


Published in:
Endoscopy, 43, 7, 604-616
Year:
2011
ISSN:
1438-8812
Keywords:
Laboratories:




 Record created 2011-06-01, last modified 2018-03-08


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)